Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 7/20 | 0.58 |
| ▸ | NPY4R | P50391 | 7/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.58 |
| ▸ | NPY1R | P25929 | 7/20 | 0.58 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.58 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.58 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.58 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.57 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.57 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.57 |
| ▸ | EP300 | Q09472 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32676360 | 0.96 | EP300 (0.59) | NPY2RNPY4RNPY5RNPY1RMAPK8 | |
| SCHEMBL30963695 | 0.95 | MAPK8 (0.58) | NPY2RNPY4RNPY5RNPY1RMAPK8 | |
| SCHEMBL30712788 | 0.93 | EP300 (0.56) | NPY2RNPY4RNPY5RNPY1RMAPK8 | |
| SCHEMBL30525422 | 0.90 | EPHA2 (0.57) | NPY2RNPY4RNPY5RNPY1REPHA2 | |
| SCHEMBL30753759 | 0.89 | NMUR2 (0.62) | NPY2RNPY4RNPY5RNPY1RMAPK8 | |
| SCHEMBL30883213 | 0.89 | NMUR2 (0.64) | NPY2RNPY4RNPY5RNPY1RNMUR2 | |
| SCHEMBL31651397 | 0.88 | NPY2R (0.71) | NPY2RNPY4RNPY5RNPY1RMAPK8 | |
| SCHEMBL30618029 | 0.88 | CALCR (0.66) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL30658265 | 0.87 | NPY2R (0.70) | NPY2RNPY4RNPY5RNPY1RMAPK8 | |
| SCHEMBL31012332 | 0.87 | TFPI (0.63) | NPY2RNPY4RNPY5RNPY1RNMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12516104-B2 | Compositions and methods for diagnosis and treatment of cancer | BioNTech SE (DE) | 2026-01-06 | — | — | US | claimed |
| US-20240002471-A1 | Compositions and Methods for Diagnosis and Treatment of Cancer | BioNTech SE (DE) | 2024-01-04 | — | — | US | claimed |
| US-12516104-B2 | Compositions and methods for diagnosis and treatment of cancer | BioNTech SE (DE) | 2026-01-06 | — | — | US | disclosed |
| US-20240002471-A1 | Compositions and Methods for Diagnosis and Treatment of Cancer | BioNTech SE (DE) | 2024-01-04 | — | — | US | disclosed |